ARCHIVES

New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor.

This article is from The Cancer Letter archive.

Vol. 32 No. 07 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

NCI To Begin Study of Augmentation Mammoplasty This Fall

May 8, 1992

Hope for FDA authority over tobacco products dies in Congress.

October 15, 2004

Funding Opportunities: DOD releases PA On Ovarian Cancer

August 6, 1999

Investigator Loses Contract Because He Had A New Idea; Virus Working Group Incensed By Unfairness

February 22, 1974

Owens Becomes President, NCCR

June 21, 1996

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997